Juvederm Injectable Gel Implants
FDA premarket approval P050047/S066 · decided 2019-03-13
Approval details
- PMA number
- P050047
- Supplement
- S066
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Juvederm Injectable Gel Implants
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Allergan
- Date received
- 2018-12-17
- Decision date
- 2019-03-13
- Days to decision
- 86 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- Approval for the addition of a 0.55 mL-fill volume configuration in the same 1.0 mL COC syringe for Juvéderm Ultra, Juvéderm Ultra XC, and Juvéderm Ultra Plus XC.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229) | Allergan | 2021-06-02 |
| TrueTear Intranasal Tear Neurostimulator (K193589) | Allergan | 2020-08-31 |
| Natrelle 133 Plus MICROCELL Tissue Expander (K180826) | Allergan | 2018-12-21 |
| Natrelle 133S Tissue Expander (K182054) | Allergan | 2018-08-29 |
| TrueTear Intranasal Tear Neurostimulator (DEN170086) | Allergan | 2018-05-17 |
| SERI SURGICAL SCAFFOLD (K123128) | Allergan | 2013-04-25 |